Home » Topics » Endocrine/metabolic, BioWorld Science

Endocrine/metabolic, BioWorld Science
RSS

Prostaglandin E1 regimen shows positive results for male erectile dysfunction

July 26, 1996

ALT-766: New AGE cross-link breaker from Alteon

July 26, 1996

Phase III results indicate Ergoset's effectiveness and safety

July 26, 1996

Selective beta3-adrenoceptor agonists in Dainippon's pipeline

July 26, 1996

Ibex licenses technology from Centre for Applied Microbiology and Research

July 26, 1996

Celtrix's SomatoKine proven safe in phase I

July 26, 1996

SR-12813: SmithKline Beecham and Symphar's hypocholesterolemic drug

July 26, 1996

Patent collaboration on bone morphogenetic/osteogenetic proteins

July 26, 1996

Boehringer Mannheim reveals acatelin, a novel ACAT inhibitor

July 26, 1996

Isolation of SOX-9 polypeptide encoding gene announced

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...